Published in

Springer Nature [academic journals on nature.com], Oncogene, 12(38), p. 2135-2150, 2018

DOI: 10.1038/s41388-018-0569-5

Links

Tools

Export citation

Search in Google Scholar

Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux

Journal article published in 2018 by Angie M. Torres-Adorno, Heidi Vitrac ORCID, Yuan Qi, Lin Tan, Kandice R. Levental, Yang-Yi Fan, Peiying Yang, Robert S. Chapkin, Bedrich L. Eckhardt ORCID, Naoto T. Ueno
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO